We are live on ! Find out more
ECM

EagleClaw Capital Management Portfolio holdings

AUM $745M
1-Year Est. Return 23.99%
This Fund
S&P 500
This Quarter Est. Return
+7.71%
1 Year Est. Return
+23.99%
3 Year Est. Return
+104.02%
5 Year Est. Return
+140.24%
10 Year Est. Return
+617.44%
AUM
$714M
AUM Growth
+$23M
Cap. Flow
+$3.98M
Cap. Flow %
0.56%
Top 10 Hldgs %
35.03%
Holding
151
New
7
Increased
37
Reduced
77
Closed
6

Top Buys

Rank Stock Value
1
AJG icon
Arthur J. Gallagher & Co
AJG
+$4.5M
2
MSFT icon
Microsoft
MSFT
+$3.95M
3
XYL icon
Xylem
XYL
+$3.2M
4
AAPL icon
Apple
AAPL
+$2.94M
5
TPL icon
Texas Pacific Land
TPL
+$2.37M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.47M
2
AIG icon
American International
AIG
+$1.79M
3
PYPL icon
PayPal
PYPL
+$1.74M
4
PCH
PotlatchDeltic
PCH
+$1.72M
5
CI icon
Cigna
CI
+$1.6M

Sector Composition

Rank Sector Weight
1 Energy 17.67%
2 Technology 16.6%
3 Industrials 12.78%
4 Consumer Discretionary 11.68%
5 Materials 10.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSGS icon
51
Madison Square Garden
MSGS
$9.94B
$3.89M 0.54%
12,095
-150
-1% -$44.7K
MRK icon
52
Merck
MRK
$334B
$3.81M 0.53%
31,638
-325
-1% -$37.5K
EMR icon
53
Emerson Electric
EMR
$91.6B
$3.44M 0.48%
26,226
-1,325
-5% -$191K
VRTX icon
54
Vertex Pharmaceuticals
VRTX
$131B
$3.3M 0.46%
7,385
COP icon
55
ConocoPhillips
COP
$150B
$3.2M 0.45%
24,252
-288
-1% -$31.9K
PFE icon
56
Pfizer
PFE
$153B
$3.12M 0.44%
111,043
+82,275
+286% +$2.19M
SYY icon
57
Sysco
SYY
$40B
$3.12M 0.44%
43,685
-800
-2% -$66.1K
CL icon
58
Colgate-Palmolive
CL
$74.1B
$3.07M 0.43%
36,079
-1,091
-3% -$97.2K
MSTR icon
59
Strategy Inc
MSTR
$38.2B
$3.02M 0.42%
24,225
-200
-0.8% -$28.6K
XYL icon
60
Xylem
XYL
$28.1B
$2.91M 0.41%
+24,375
New +$3.2M
BDX icon
61
Becton Dickinson
BDX
$49.6B
$2.86M 0.4%
18,195
-4,476
-20% -$822K
HON icon
62
Honeywell
HON
$74.2B
$2.84M 0.4%
12,566
+10
+0.1% +$2.29K
MDT icon
63
Medtronic
MDT
$116B
$2.84M 0.4%
32,747
+600
+2% +$57.5K
VTI icon
64
Vanguard Morningstar Total Stock Market ETF
VTI
$696B
$2.8M 0.39%
8,732
+300
+4% +$101K
TMO icon
65
Thermo Fisher Scientific
TMO
$220B
$2.77M 0.39%
5,629
-605
-10% -$328K
UPS icon
66
United Parcel Service
UPS
$89.8B
$2.71M 0.38%
27,513
-5,303
-16% -$569K
BAC icon
67
Bank of America
BAC
$448B
$2.49M 0.35%
51,139
-1,725
-3% -$89K
SNY icon
68
Sanofi
SNY
$105B
$2.45M 0.34%
50,835
-550
-1% -$25.6K
HOLX
69
DELISTED
Hologic
HOLX
$2.42M 0.34%
31,984
-1,848
-5% -$139K
NVO
70
Novo Nordisk
NVO
$205B
$2.36M 0.33%
64,200
-450
-0.7% -$21.3K
MTG icon
71
MGIC Investment
MTG
$6.33B
$2.35M 0.33%
89,550
-250
-0.3% -$6.68K
CI icon
72
Cigna
CI
$73.5B
$2.25M 0.31%
8,429
-5,772
-41% -$1.6M
DVN icon
73
Devon Energy
DVN
$48.8B
$2.23M 0.31%
44,400
-1,075
-2% -$46.1K
BMY icon
74
Bristol-Myers Squibb
BMY
$132B
$2.23M 0.31%
36,693
-7,725
-17% -$450K
MKC icon
75
McCormick & Company Non-Voting
MKC
$14.6B
$2.15M 0.3%
42,535
+4,340
+11% +$276K

Similar funds

EagleClaw Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, EagleClaw Capital Management held 151 positions worth $714M, up 3.3% from $691M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

EagleClaw Capital Management's Q1 2026 filing shows 7 new, 37 increased, 77 reduced and 6 closed positions. Its largest new stake was Xylem: 24,375 shares worth $2.91M. The largest sale was NVIDIA, an estimated $2.47M.

By sector, the portfolio is most concentrated in Energy at 18% of assets, up from 12% a quarter earlier, followed by Technology and Industrials.

  • EagleClaw Capital Management's largest Q1 2026 buy was Xylem: 24,375 shares worth $2.91M.
  • EagleClaw Capital Management added most to Arthur J. Gallagher & Co in Q1 2026, an estimated $4.5M increase.
  • EagleClaw Capital Management's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $2.47M.
  • EagleClaw Capital Management fully exited PotlatchDeltic in Q1 2026, selling an estimated $1.72M.
  • EagleClaw Capital Management's ten largest holdings make up 35% of its $714M portfolio in Q1 2026.
  • EagleClaw Capital Management opened 7 new positions and closed 6 in Q1 2026.
  • EagleClaw Capital Management's portfolio value rose 3.3% quarter-over-quarter to $714M.

Based on EagleClaw Capital Management's 13F filing for Q1 2026, filed 8 May 2026.